论文部分内容阅读
目的探究思密达联合妈咪爱治疗新生儿黄疸的临床疗效。方法选取在我院治疗的新生儿黄疸患儿32例,随机分为观察组和对照组各16例,对照组给予患儿常规对症治疗,观察组在对照组的基础上加用思密达联合妈咪爱治疗,对比两组患儿胆红素降低水平、黄疸消退时间及总有效率。结果观察组患儿总有效率明显高于对照组,两组患者的临床疗效对比差异具有统计学意义(P<0.05)。观察组患儿胆红素每日平均下降值为(48.9±18.2)μmol/L;对照组患儿胆红素每日平均下降值为(37.9±16.5)μmol/L;两组胆红素下降水平对比,差异具有统计学意义(P<0.05);观察组患儿黄疸消退时间为(3.8±2.2)d;对照组患儿黄疸消退时间为(5.6±2.6)d;两组患儿黄疸消退时间对比,差异具有统计学意义(P<0.05)。结论思密达联合妈咪爱治疗新生儿黄疸疗效确切,不良反应少,缩短患儿的治疗时间,值得临床推广应用。
Objective To explore the clinical efficacy of Smecta combined with Mommy Love in the treatment of neonatal jaundice. Methods 32 cases of neonatal jaundice treated in our hospital were randomly divided into observation group and control group, 16 cases in each group. The control group was given conventional symptomatic treatment. The observation group was treated with the combination of Smectite Mummy love treatment, compared with two groups of children with bilirubin levels, jaundice subsided time and the total effective rate. Results The total effective rate in observation group was significantly higher than that in control group. There was significant difference in clinical curative effect between the two groups (P <0.05). The mean daily decline of bilirubin in the observation group was (48.9 ± 18.2) μmol / L, while the mean daily decrease of bilirubin in the control group was (37.9 ± 16.5) μmol / L. The bilirubin (3.8 ± 2.2) days in the observation group and (5.6 ± 2.6) days in the control group. The jaundice in the two groups was subsided (P <0.05), and the difference was statistically significant Time contrast, the difference was statistically significant (P <0.05). Conclusion Smecta combined mommy love treatment of neonatal jaundice exact effect, fewer adverse reactions, shorten the treatment time in children worthy of clinical promotion and application.